Overview

Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury

Status:
Terminated

Trial end date:
2011-01-01

Target enrollment:

Participant gender:

Summary

The primary objective of the study is to determine whether armodafinil treatment is more effective than placebo treatment in patients with excessive sleepiness associated with mild or moderate closed traumatic brain injury (TBI).

Phase:

Phase 3

Details

Lead Sponsor:

Cephalon

Treatments:

Armodafinil
Modafinil